Inpharma Weekly

, Volume 1189, Issue 1, pp 3–4 | Cite as

Ethical considerations in the coverage of ‘lifestyle’ drugs

  • Dilesh Doshi
Newsletter Article


One of the most difficult challenges that policy-makers will face in the next 10 years is tackling the ethical considerations involved in the coverage of so-called ‘lifestyle’ drugs. Should health plans provide coverage for such drugs? If so, should limits be set? And will limits jeopardise physician-patient relationships? At the sixth annual Drug Information Association symposium on Quality of Life Evaluation [ Hilton Head, South Carolina, US; March 1999 ], Dr James Sabin shared his experience in establishing coverage policies and provided some answers to these questions. *


Health Plan Public Disclosure Drug Coverage Coverage Policy Harvard Pilgrim Health 

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Dilesh Doshi

There are no affiliations available

Personalised recommendations